282 related articles for article (PubMed ID: 14231545)
1. A COMPARISON OF THE APPETITE SUPPRESSING PROPERTIES OF DEXAMPHETAMINE AND PHENTERMINE.
SEATON DA; ROSE K; DUNCAN LJ
Scott Med J; 1964 Nov; 9():482-5. PubMed ID: 14231545
[No Abstract] [Full Text] [Related]
2. THE USES AND ABUSES OF APPETITE SUPPRESSANTS.
SEATON DA; DUNCAN LJ
Br J Clin Pract; 1965 Feb; 19():89-93. PubMed ID: 14258387
[No Abstract] [Full Text] [Related]
3. SUSTAINED-ACTION AMPHETAMINE-MEPROBAMATE COMBINATION FOR THE TREATMENT OF OBESITY.
BATTERMAN RC
Curr Ther Res Clin Exp; 1964 Jul; 6():447-53. PubMed ID: 14203275
[No Abstract] [Full Text] [Related]
4. APPETITE SUPPRESSING DRUGS AS AN ETIOLOGIC FACTOR IN MENTAL ILLNESS.
BREITNER C
Psychosomatics; 1963; 4():327-33. PubMed ID: 14060673
[No Abstract] [Full Text] [Related]
5. PSYCHOPHARMACOLOGY OF CHLORPHENTERMINE AND D-AMPHETAMINE. A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES.
DIMASCIO A; BUIE DH
Clin Pharmacol Ther; 1964; 5():174-84. PubMed ID: 14155159
[No Abstract] [Full Text] [Related]
6. HYPERTENSION AND TRANYLCYPROMINE.
MENDELS J
Am J Psychiatry; 1964 Dec; 121():595-7. PubMed ID: 14239464
[No Abstract] [Full Text] [Related]
7. OBESITY TREATMENT OF COMPLICATED AND UNCOMPLICATED CASES WITH CHLORPHENTERMINE HYDROCHLORIDE.
BERRY RL
Ind Med Surg; 1965 Jun; 34():490-2. PubMed ID: 14308330
[No Abstract] [Full Text] [Related]
8. Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
De Felice EA; Cohen A; Schmitz PL; Rothwell KG; Truant AP
J Clin Pharmacol J New Drugs; 1968; 8(6):360-9. PubMed ID: 4883784
[No Abstract] [Full Text] [Related]
9. Value of ephedrine-ethlenediamine as an appetite depressant: comparison with d-amphetamine sulfate.
KUPERSMITH IH
Curr Ther Res Clin Exp; 1960 Feb; 2():39-42. PubMed ID: 14412826
[No Abstract] [Full Text] [Related]
10. CONTROL OF OBESITY IN THE CARDIAC PATIENT.
RUSSEK HI
Am J Med Sci; 1965 Mar; 249():305-8. PubMed ID: 14273320
[No Abstract] [Full Text] [Related]
11. SUSTAINED RELEASE APPETITE SUPPRESSANT COMBINED WITH REDUCING DIET.
LERICHE WH; CSIMA A
Appl Ther; 1965 Mar; 7():226-8. PubMed ID: 14266244
[No Abstract] [Full Text] [Related]
12. A determination of the anorexigenic potential of dl-amphetamine, d-amphetamine, l-amphetamine and phentermine.
Lawlor RB; Trivedi MC; Yelnosky J
Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):401-7. PubMed ID: 5367311
[No Abstract] [Full Text] [Related]
13. ACUTE PSYCHOTIC REACTION FOLLOWING INGESTION OF PHENTERMINE.
RUBIN RT
Am J Psychiatry; 1964 May; 120():1124-5. PubMed ID: 14144446
[No Abstract] [Full Text] [Related]
14. USE OF AN AMPHETAMINE-COMBINATION DRUG IN AN ANTI-OBESITY CLINIC.
BERMAN MI; ANDERSON IR
Md State Med J; 1965 Jan; 14():29-31. PubMed ID: 14233312
[No Abstract] [Full Text] [Related]
15. [ON THE DRUG THERAPY OF OBESITY].
NEUBERT D
Z Arztl Fortbild (Berl); 1965 Feb; 54():134-46. PubMed ID: 14266804
[No Abstract] [Full Text] [Related]
16. SYMPATHOMIMETIC DRUG-INDUCED PSYCHOSIS.
MURRAY PA
J Ir Med Assoc; 1964 Jan; 54():21-3. PubMed ID: 14105269
[No Abstract] [Full Text] [Related]
17. A STUDY OF OBESITY IN GENERAL PRACTICE.
BEW K
Ulster Med J; 1964 Jun; 33(1):43-8. PubMed ID: 14177397
[No Abstract] [Full Text] [Related]
18. MANAGEMENT OF THE OBESE PATIENT: A REVIEW OF ADJUNCTIVE MEASURES.
EHRMANTRAUT WR; SAVARESE CJ
J Am Med Womens Assoc; 1964 Sep; 19():750-4. PubMed ID: 14173959
[No Abstract] [Full Text] [Related]
19. A PRELIMINARY TRIAL OF FENFLURAMINE IN GENERAL PRACTICE.
DUNCAN EH; HYDE CA; REGAN NA; SWEETMAN B
Br J Clin Pract; 1965 Aug; 19():451-2. PubMed ID: 14324832
[No Abstract] [Full Text] [Related]
20. Pharmacology of phentermine.
Yelnosky J; Panasevich RE; Borrelli AR; Lawlor RB
Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):62-76. PubMed ID: 5353475
[No Abstract] [Full Text] [Related]
[Next] [New Search]
